Our results are in agreement with two recent reports by Nakayama et al. and Shimizu et al. In those two studies, which included 43 and 56 Japanese patients with SSc, respectively, serum concentration of sCD163 was significantly higher in scleroderma patients compared with the control group [23,24]. The gene discussed is CD163; the disease is systemic sclerosis.